NVAX Novavax, Inc. Stock Quote

NVAX [NASD]

Index	-	P/E	-	EPS (ttm)	-19.41	Insider Own	0.20%	Shs Outstand	78.14M	Perf Week	-30.94%
Market Cap	1.76B	Forward P/E	8.15	EPS next Y	2.58	Insider Trans	-6.96%	Shs Float	77.85M	Perf Month	-43.35%
Income	-1475.80M	PEG	-	EPS next Q	1.58	Inst Own	44.50%	Short Float	20.06%	Perf Quarter	-59.36%
Sales	1.29B	P/S	1.36	EPS this Y	-222.50%	Inst Trans	1.80%	Short Ratio	2.55	Perf Half Y	-73.81%
Book/sh	-5.34	P/B	-	EPS next Y	753.50%	ROA	-55.70%	Target Price	105.83	Perf Year	-90.95%
Cash/sh	-	P/C	-	EPS next 5Y	0.00%	ROE	-	52W Range	20.46 - 257.30	Perf YTD	-85.32%
Dividend	-	P/FCF	-	EPS past 5Y	-2.50%	ROI	-	52W High	-92.40%	Beta	1.76
Dividend %	-	Quick Ratio	0.90	Sales past 5Y	136.90%	Gross Margin	77.80%	52W Low	-4.40%	ATR	2.46
Employees	1541	Current Ratio	1.00	Sales Q/Q	-37.60%	Oper. Margin	-	RSI (14)	22.88	Volatility	9.61% 7.76%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-37.40%	Profit Margin	-	Rel Volume	0.81	Prev Close	21.00
Shortable	Yes	LT Debt/Eq	-	Earnings	Aug 08 AMC	Payout	-	Avg Volume	6.13M	Price	19.56
Recom	2.50	SMA20	-35.63%	SMA50	-53.10%	SMA200	-73.06%	Volume	3,604,013	Change	-6.86%

Sep-22-22

Downgrade

JP Morgan

Neutral → Underweight

$132 → $27

May-20-22

Initiated

BofA Securities

Underperform

$35

Feb-23-22

Reiterated

B. Riley Securities

Buy

$315 → $265

Feb-22-22

Resumed

Jefferies

Buy

$198

Jan-21-22

Initiated

Cowen

Outperform

$150

May-12-21

Downgrade

JP Morgan

Overweight → Neutral

$285 → $161

Dec-14-20

Initiated

Jefferies

Buy

$200

Aug-06-20

Reiterated

H.C. Wainwright

Buy

$132 → $290

Aug-05-20

Upgrade

JP Morgan

Neutral → Overweight

$275

Aug-05-20

Downgrade

Ladenburg Thalmann

Neutral → Sell

$105

Jul-16-20

Reiterated

H.C. Wainwright

Buy

$101 → $132

Jul-08-20

Downgrade

Ladenburg Thalmann

Buy → Neutral

$50 → $105

Jun-29-20

Reiterated

H.C. Wainwright

Buy

$50 → $101

Jun-29-20

Reiterated

B. Riley FBR

Buy

$74 → $106

Jun-05-20

Upgrade

JP Morgan

Underweight → Neutral

$46

May-28-20

Reiterated

B. Riley FBR

Buy

$53 → $61

May-12-20

Reiterated

H.C. Wainwright

Buy

$33 → $50

Apr-30-20

Reiterated

H.C. Wainwright

Buy

$24 → $33

Nov-27-19

Resumed

B. Riley FBR

Buy

$12

Aug-14-19

Reiterated

H.C. Wainwright

Buy

$10 → $17

Sep-26-22 06:00AM	Down 85%, Is There Any Hope for This Struggling Vaccine Stock? Motley Fool -6.86%
Sep-25-22 06:07AM	Novavax Downgraded by JPMorgan Chase. Time to Sell? Motley Fool
Sep-24-22 08:14AM	Some Novavax, Inc. (NASDAQ:NVAX) Analysts Just Made A Major Cut To Next Year's Estimates Simply Wall St.
Sep-23-22 06:13PM	Novavax, Inc. stock performance and analyst projections Yahoo Finance Video -6.42%
10:51AM	Why Novavax (NVAX) Stock Was Down 13% on Thursday Zacks

Sep-22-22 04:43PM	Why Novavax Stock Is Plunging This Week Motley Fool -13.26%
04:11PM	Here Are Novavax's U.S. Vaccination Numbers And They're Bleak Investor's Business Daily
02:00PM	Novavax's Covid Vaccine May Pinch, But the Charts Really Hurt TheStreet.com
01:17PM	Novavax Stock Sinks. It Has Few Levers for Covid Vaccine, Says New Bear. Barrons.com
11:15AM	Why Novavax Stock Hit a Fresh 52-Week Low Today Motley Fool
10:53AM	Novavax stock dives after JPMorgan downgrades shares Yahoo Finance Video
10:26AM	Novavax stock extends plunge after J.P. Morgan turns bearish, on expectations of more guidance cuts MarketWatch
10:06AM	Midday Movers: Novavax, Robinhood Markets, Royal Caribbean and More Investing.com
08:11AM	Novavax Stock Slides As JPMorgan Slashes Price Target, Lowers Rating TheStreet.com
03:49AM	Lennar, Darden Restaurants, Novavax Fall Premarket; Eli Lilly, H.B. Fuller Rise Investing.com

Sep-20-22 09:00AM	Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? Zacks
Sep-19-22 06:18PM	Why Novavax and Johnson & Johnson Stocks Slipped Today Motley Fool -6.51%
11:31AM	Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over MarketWatch
Sep-18-22 10:28AM	Despite currently being unprofitable, Novavax (NASDAQ:NVAX) has delivered a 364% return to shareholders over 3 years Simply Wall St.
Sep-17-22 05:00AM	America is skeptical of the 'dark horse' COVID vaccine others abroad can't get enough of Fortune
Sep-16-22 08:18AM	Novavax says its COVID vaccine is now available in Israel for use in people aged 12 and older MarketWatch -6.57%
08:15AM	Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Emergency Use Authorization in Taiwan for Use in Adolescents Aged 12 Through 17 PR Newswire
08:10AM	Novavax Nuvaxovid COVID-19 Vaccine Now Available in Israel for Individuals Aged 12 and Older PR Newswire
Sep-15-22 05:50PM	Novavax (NVAX) Flat As Market Sinks: What You Should Know Zacks
12:25PM	Is Novavax A Sell After Its Quarterly Flop Led To A Guidance Cut? Investor's Business Daily
Sep-14-22 04:35PM	Biotech Stock Roundup: BMY Surges on Drug Approval, REGN Up on Update & More Zacks +5.75%
Sep-13-22 11:20AM	Novavax (NVAX) Gets EU Nod for COVID-19 Booster Jab in Adults Zacks -6.73%
08:00AM	Novavax and Serum Institute of India Announce Full Product Registration in South Africa of Novavax COVID-19 Vaccine as a Primary Series for Adults Aged 18 and Older PR Newswire
Sep-12-22 11:16AM	Europe Approves Novavax's COVID-19 Vaccine Booster For Adults Benzinga
10:25AM	Novavax's COVID-19 booster is now authorized in Europe MarketWatch

09:23AM	Novavax Nuvaxovid COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the European Union for Use as a Booster for Adults Aged 18 and Older PR Newswire
07:37AM	3 Stocks Expecting Good News From the FDA Motley Fool
Sep-08-22 01:00PM	Here's Why These Top 3 COVID-19 Vaccine Stocks Broke Down in August Motley Fool
10:45AM	Nasdaq Bear Market: 3 Growth Stocks That Crashed Over 30% in August Motley Fool
Sep-07-22 04:02PM	Novavax to Participate in Upcoming September Conferences PR Newswire +7.33%
11:30AM	Novavax (NVAX) Down 29.2% Since Last Earnings Report: Can It Rebound? Zacks
09:00AM	Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now? Zacks
Sep-06-22 12:35PM	Why Novavax Stock Sank to a New 52-Week Low Today Motley Fool -6.12%
Sep-05-22 01:08PM	Novavax's (NVAX) COVID-19 Jab Gets Approval in Switzerland Zacks
Sep-02-22 01:56PM	Swissmedic Authorizes Novavax Nuvaxovid COVID-19 Vaccine for Adolescents Aged 12 Through 17 and as a Booster in Adults Aged 18 and Older PR Newswire
01:45PM	Novavax's (NVAX) COVID-19 Booster Gets CHMP Recommendation Zacks
Sep-01-22 01:37PM	Novavax Nuvaxovid COVID-19 Vaccine Recommended by CHMP for Expanded Conditional Marketing Authorization in the European Union as a Booster for Adults Aged 18 and Older PR Newswire
11:02AM	UPDATE 1-EU regulator backs use of Novavax COVID shot as a booster Reuters
Aug-31-22 06:45PM	Why Novavax Stock Got Pummeled Today Motley Fool -6.19%
02:54PM	Why Is Novavax (NVAX) Stock Down Today? InvestorPlace
05:21AM	Nasdaq Bear Market: 3 Supercharged Growth Stocks That Can Double Your Money by 2025 Motley Fool
Aug-30-22 06:00AM	After Double-Digit Percentage Declines, Are Vaccine Stocks Buys? Motley Fool
Aug-29-22 08:54AM	Do Options Traders Know Something About Novavax (NVAX) Stock We Don't? Zacks
Aug-27-22 06:08AM	3 Growth Stocks Poised to Skyrocket Motley Fool
Aug-26-22 03:22PM	The Covid Gambit: Pfizer, Moderna Struggle To Get The Jump On Covid Investor's Business Daily -5.50%
12:46PM	Novavax Scores Another Nod For Its COVID-19 Shot In Adolescents Benzinga
09:27AM	Novavax Nuvaxovid COVID-19 Vaccine Granted Expanded Conditional Marketing Authorization in the United Kingdom for Use in Adolescents Aged 12 Through 17 PR Newswire
Aug-24-22 04:31PM	Africa: Why COVID vaccine inequity is still a big, and deadly, problem for all of us Yahoo Finance
Aug-23-22 09:25AM	With CDC signoff, Novavax clears final hurdle to get Covid vaccine to teenagers American City Business Journals
Aug-22-22 05:29PM	Why Novavax Fell Today Despite Its Sunny News Motley Fool
04:16PM	Pfizer, BioNTech Seek FDA Authorization for Updated Covid-19 Vaccine The Wall Street Journal
12:33PM	Novavax (NVAX) COVID-19 Vaccine Gets FDA Nod for Adolescents Zacks
11:42AM	UPDATE 1-U.S. CDC recommends use of Novavax's COVID shot for adolescents Reuters
10:43AM	Jill Biden leaves isolation after twice testing negative, and Novavax vaccine is now allowed for U.S. teens MarketWatch
09:30AM	1 Green Flag and 1 Red Flag for Novavax Motley Fool
08:04AM	FDA Approves Novavax's COVID-19 Vaccine For Use In Adolescents Benzinga
07:36AM	Novavax's Covid-19 vaccine wins FDA approval for children ages 12 to 17 American City Business Journals
Aug-21-22 10:05PM	U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17 PR Newswire
08:45AM	The Rise and Fall of Novavax Motley Fool
Aug-19-22 07:14PM	Novavax COVID-19 vaccine authorized for U.S. teens MarketWatch
06:23PM	U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17 CNW Group
04:13PM	Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions Investor's Business Daily
11:00AM	2 Overrated Growth Stocks I Wouldn't Buy With Free Money Motley Fool
Aug-18-22 12:18PM	Novavax's Covid-19 Vaccine Cleared For Use In New Zealanders Aged 12-17 Benzinga -5.56%
08:54AM	Novavax Nuvaxovid COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand for Adolescents Aged 12 Through 17 PR Newswire
08:00AM	Missed BBBY? 10 'Meme Stocks' Are Next Gold Mines, Analysts Say Investor's Business Daily
Aug-17-22 12:18PM	U.S. to end purchase of COVID-19 vaccines as industry pivots to commercial market Yahoo Finance -8.19%
08:00AM	Novavax Nuvaxovid COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults PR Newswire
Aug-16-22 12:32PM	Novavax (NVAX) Seeks FDA Authorization for COVID-19 Booster Dose Zacks
Aug-15-22 06:45PM	Why Novavax Stock Eked Out a Gain Today Motley Fool
11:08AM	Novavax seeks FDAs green light for Covid vaccine as a booster American City Business Journals
10:04AM	U.K. regulator is first to authorize Modernas bivalent COVID booster for 18-and-older population MarketWatch
09:28AM	Novavax Seeks FDA Emergency Use Nod For Its COVID-19 Vaccine Booster Benzinga
08:39AM	Novavax's (NVAX) COVID Vaccine Aids Growth, Overdependence Ails Zacks
08:19AM	UPDATE 2-Novavax seeks U.S. authorization for COVID vaccine booster Reuters
08:14AM	Novavax submits FDA application for its COVID-19 booster MarketWatch
08:00AM	Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and Older PR Newswire
Aug-14-22 09:53AM	2 Tips for Investing in Biotech Stocks With High Growth Potential Motley Fool
Aug-12-22 10:30AM	1 Robinhood Stock to Avoid Right Now Motley Fool
09:39AM	Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17 PR Newswire
09:22AM	Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17 PR Newswire
07:45AM	Why Novavax Stock Was Plummeting This Week Motley Fool
05:52AM	Novavax's Revenue Could Fall Even More -- and It's Actually Good News Motley Fool
Aug-11-22 04:02PM	Novavax to Participate in Fireside Chat at the SVB Securities Virtual Vaccine Forum PR Newswire
06:15AM	These Analysts Just Made An Downgrade To Their Novavax, Inc. (NASDAQ:NVAX) EPS Forecasts Simply Wall St.
Aug-10-22 03:16PM	Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y Zacks
01:15PM	1 Reason to Sell Novavax Stock, and 1 Reason to Buy Motley Fool
05:21AM	Nasdaq Bear Market: 3 Remarkable Growth Stocks That Can Double Your Money by 2026 Motley Fool
Aug-09-22 04:15PM	Novavax Rout Extends 87% From Peak Amid Covid-Shot Setbacks Bloomberg -29.64%
04:05PM	Novavax Stock Plummets As 'Market Dynamics' Crush Its 2022 Sales Outlook Investor's Business Daily
04:00PM	US STOCKS-Nasdaq closes lower as chipmaker Micron's warning renews tech rout Reuters
03:59PM	As Covid Vaccine Boom Ends, Pfizer and Moderna Pursue Opposite Strategies Barrons.com
03:06PM	US STOCKS-Nasdaq slides 1% as chipmaker Micron's warning renews tech rout Reuters
01:41PM	Novavax does not have a forecast for U.S. orders in 2022: CEO Erck Yahoo Finance
12:58PM	Novavax Stock Slides 31%. It Sees a Shortfall in Demand for Covid-19 Vaccines. Barrons.com

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
YOUNG JAMES F	Director	Mar 31	Sale	73.58	12,500	919,765	62,590	Apr 04 05:14 PM
Herrmann John A III	EVP, Chief Legal Officer	Jan 03	Option Exercise	19.08	5,000	95,400	8,845	Jan 05 05:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Jan 03	Sale	140.91	5,000	704,534	3,845	Jan 05 05:22 PM
YOUNG JAMES F	Director	Dec 31	Option Exercise	25.60	3,750	96,000	78,840	Jan 04 05:04 PM
YOUNG JAMES F	Director	Dec 31	Sale	144.16	3,750	540,601	75,090	Jan 04 05:04 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 20	Option Exercise	19.08	5,000	95,400	8,845	Dec 22 05:03 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 20	Sale	230.00	5,000	1,150,000	3,845	Dec 22 05:03 PM
Glenn Gregory M	President, R&D	Dec 15	Option Exercise	34.82	1,686	58,714	7,349	Dec 16 05:15 PM
Glenn Gregory M	President, R&D	Dec 15	Sale	174.13	1,686	293,584	5,663	Dec 16 05:15 PM
DOUGLAS RICHARD	Director	Dec 13	Option Exercise	25.60	1,500	38,400	33,450	Dec 15 05:22 PM
Glenn Gregory M	President, R&D	Dec 07	Option Exercise	19.08	8,250	157,410	12,311	Dec 09 05:20 PM
Glenn Gregory M	President, R&D	Dec 07	Sale	170.14	8,250	1,403,631	4,061	Dec 09 05:20 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 01	Option Exercise	19.08	5,000	95,400	7,760	Dec 03 06:30 PM
Herrmann John A III	EVP, Chief Legal Officer	Dec 01	Sale	196.19	5,000	980,944	2,760	Dec 03 06:30 PM
Glenn Gregory M	President, R&D	Nov 30	Option Exercise	19.08	8,250	157,410	13,003	Dec 02 04:13 PM
Glenn Gregory M	President, R&D	Nov 30	Sale	203.20	8,942	1,817,000	4,061	Dec 02 04:13 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 29	Option Exercise	19.08	5,000	95,400	7,760	Dec 01 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 29	Sale	228.72	5,000	1,143,600	2,760	Dec 01 05:02 PM
Glenn Gregory M	President, R&D	Nov 26	Option Exercise	5.95	3,460	20,587	6,144	Nov 30 05:06 PM
Glenn Gregory M	President, R&D	Nov 26	Sale	218.07	2,083	454,247	4,061	Nov 30 05:06 PM
Glenn Gregory M	President, R&D	Nov 23	Option Exercise	19.08	8,250	157,410	12,311	Nov 24 05:21 PM
Glenn Gregory M	President, R&D	Nov 23	Sale	199.50	8,250	1,645,914	4,061	Nov 24 05:21 PM
Glenn Gregory M	President, R&D	Nov 16	Option Exercise	19.08	8,250	157,410	12,311	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 16	Sale	169.48	8,250	1,398,180	4,061	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 15	Option Exercise	37.90	1,183	44,832	5,244	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 15	Sale	172.02	1,183	203,496	4,061	Nov 17 05:25 PM
Glenn Gregory M	President, R&D	Nov 09	Option Exercise	19.08	8,250	157,410	12,311	Nov 12 05:02 PM
Glenn Gregory M	President, R&D	Nov 09	Sale	167.53	8,250	1,382,160	4,061	Nov 12 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 03	Option Exercise	19.08	5,000	95,400	7,760	Nov 05 05:02 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 03	Sale	200.00	5,000	1,000,000	2,760	Nov 05 05:02 PM
Glenn Gregory M	President, R&D	Nov 02	Option Exercise	19.08	8,250	157,410	12,311	Nov 04 05:22 PM
Glenn Gregory M	President, R&D	Nov 02	Sale	183.82	8,250	1,516,552	4,061	Nov 04 05:22 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 01	Option Exercise	19.08	5,000	95,400	7,760	Nov 03 04:49 PM
Herrmann John A III	EVP, Chief Legal Officer	Nov 01	Sale	163.08	5,000	815,422	2,760	Nov 03 04:49 PM
Glenn Gregory M	President, R&D	Oct 29	Sale	148.34	680	100,871	4,061	Nov 02 07:02 PM
Glenn Gregory M	President, R&D	Oct 26	Option Exercise	15.20	11,712	178,009	14,395	Oct 28 05:09 PM
Glenn Gregory M	President, R&D	Oct 26	Sale	132.73	10,334	1,371,667	4,061	Oct 28 05:09 PM
Glenn Gregory M	President, R&D	Oct 19	Option Exercise	19.08	8,250	157,410	12,311	Oct 21 05:08 PM
Glenn Gregory M	President, R&D	Oct 19	Sale	165.14	8,250	1,362,427	4,061	Oct 21 05:08 PM
Glenn Gregory M	President, R&D	Oct 15	Option Exercise	37.90	1,183	44,832	5,244	Oct 19 05:04 PM
Glenn Gregory M	President, R&D	Oct 15	Sale	170.00	1,183	201,110	4,061	Oct 19 05:04 PM
Glenn Gregory M	President, R&D	Oct 12	Option Exercise	19.08	8,250	157,410	12,311	Oct 14 05:16 PM
Glenn Gregory M	President, R&D	Oct 12	Sale	163.18	8,250	1,346,218	4,061	Oct 14 05:16 PM
Glenn Gregory M	President, R&D	Oct 05	Option Exercise	19.08	8,250	157,410	12,311	Oct 07 05:18 PM
Glenn Gregory M	President, R&D	Oct 05	Sale	174.41	8,250	1,438,895	4,061	Oct 07 05:18 PM
Erck Stanley C	President and CEO	Oct 04	Option Exercise	27.45	42,829	1,175,583	66,708	Oct 05 05:05 PM
Erck Stanley C	President and CEO	Oct 04	Sale	176.15	42,829	7,544,195	23,879	Oct 05 05:05 PM
Herrmann John A III	EVP, Chief Legal Officer	Oct 01	Option Exercise	19.08	5,000	95,400	7,760	Oct 05 05:02 PM
Erck Stanley C	President and CEO	Oct 01	Option Exercise	27.17	49,000	1,331,400	72,879	Oct 05 05:04 PM
Erck Stanley C	President and CEO	Oct 01	Sale	175.10	49,000	8,580,064	23,879	Oct 05 05:04 PM
Herrmann John A III	EVP, Chief Legal Officer	Oct 01	Sale	174.89	5,000	874,452	2,760	Oct 05 05:02 PM
Glenn Gregory M	President, R&D	Sep 30	Sale	207.25	693	143,622	4,061	Oct 01 05:58 PM
Trizzino John	EVP, CCO and CBO	Sep 28	Option Exercise	19.08	7,501	143,119	10,047	Sep 29 05:06 PM
Trizzino John	EVP, CCO and CBO	Sep 28	Sale	209.92	7,501	1,574,637	2,546	Sep 29 05:06 PM
Trizzino John	EVP, CCO and CBO	Sep 27	Option Exercise	19.08	7,501	143,119	10,047	Sep 29 05:04 PM
Glenn Gregory M	President, R&D	Sep 27	Option Exercise	5.95	3,460	20,587	6,144	Sep 29 05:08 PM
Glenn Gregory M	President, R&D	Sep 27	Sale	234.43	2,083	488,315	4,061	Sep 29 05:08 PM
Trizzino John	EVP, CCO and CBO	Sep 27	Sale	234.61	7,501	1,759,833	2,546	Sep 29 05:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience